Treatment with intensive insulin therapy for the management of T1DM was established as the standard of care based on the results of the Diabetes Control and Complication Trial (DCCT) [2] and can be administered with multiple daily injections (MDI) or an insulin pump (CSII). This evidence concerns the gene INS and diabetes mellitus.